Table 3. Rate of coronary death or non-fatal MI (by age and eGFR).
|
Rate (95% CI) of coronary death or non-fatal MI (per 1000 patient-years) |
|||
|---|---|---|---|
| Overall | Male | Female | |
| Age >40 years (eGFR G1-G4) | 14.9 (14.6–15.3) | 17.4 (16.9–17.9) | 12.7 (12.3–13.1) |
| eGFR G3a-G4 | 19.3 (18.8–19.8) | 23.4 (22.6–24.2) | 16.4 (15.8–17.0) |
| eGFR G1-G2 | 9.7 (9.3–10.0) | 12.0 (11.4–12.6) | 6.7 (6.3, 7.2) |
| Age >50 years (eGFR G1-G4) | 17.3 (17.0–17.7) | 20.2 (19.6–20.8) | 14.8 (14.3–15.3) |
| eGFR G3a-G4 | 19.9 (19.4–20.4) | 24.3 (23.4–25.2) | 16.9 (16.3–17.5) |
| eGFR G1-G2 | 12.9 (12.4–13.4) | 15.2 (14.5–16.0) | 9.7 (9.0–10.5) |
| Age 40–50 years (eGFR G1-G4) | 3.2 (2.9–3.6) | 4.7 (4.2–5.4) | 1.6 (1.2–2.0) |
| eGFR G3a-G4 | 4.7 (3.7–6.0) | 5.9 (4.3–8.1) | 3.6 (2.5–5.3) |
| eGFR G1-G2 | 3.0 (2.6–3.3) | 4.6 (4.0–5.3) | 1.2 (0.9–1.6) |
Abbreviations: CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction.
Data are unadjusted rates from 1,268,029 participants in the Alberta Kidney Disease cohort. People with diabetes, MI, and other cardiovascular disease were included. Data do not apply to people with kidney transplants.